Insights

Loading spinner
Gathering insights about Oncovalent Therapeutics

Oncovalent Therapeutics Tech Stack

Media & News

Oncovalent Therapeutics's Email Address Formats

Oncovalent Therapeutics uses at least 1 format(s):
Oncovalent Therapeutics Email FormatsExamplePercentage
FLast@oncovalent.comJDoe@oncovalent.com
100%

Frequently Asked Questions

What is Oncovalent Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Oncovalent Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oncovalent Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Oncovalent Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Senior Research Associate, Chemistry: P. B.. Explore Oncovalent Therapeutics's employee directory with LeadIQ.

What industry does Oncovalent Therapeutics belong to?

Minus sign iconPlus sign icon
Oncovalent Therapeutics operates in the Biotechnology Research industry.

What is Oncovalent Therapeutics's email format?

Minus sign iconPlus sign icon
Oncovalent Therapeutics's email format typically follows the pattern of FLast@oncovalent.com. Find more Oncovalent Therapeutics email formats with LeadIQ.

When was Oncovalent Therapeutics founded?

Minus sign iconPlus sign icon
Oncovalent Therapeutics was founded in 2020.

Oncovalent Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

We are a new early stage small molecule company focused on oncology therapeutics.   We leverage our expertise in medicinal chemistry and biology to advance drug candidates with the potential to deliver significant clinical benefit to patients suffering from cancer.  Located in Newbury Park, California, we have an exceptionally talented team of experienced researchers and drug developers dedicated to high quality science and innovation as we aim to build a dynamic and successful oncology company.  
 

The know-how and technologies within Oncovalent Therapeutics provides the opportunity to identify and develop selective small molecule therapies for cancer.  We focus on challenging, disease-relevant pathways and translate insights into innovative medicines. 

The oncology patient is at the center of everything we do. We hire exceptional people with the same passion for patients and cutting-edge science to eradicate cancer in our lifetime.  Check out our open positions if you are interested in contributing to our mission and vision.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Oncovalent Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Oncovalent Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.